Statins have been suggested to be of use in breast cancer therapy [162,163] and treatment of breast cancer cells with lovastatin led to an overexpression of PTEN and a resulting decrease in AKT/PKB signaling [164]. This evidence concerns the gene AKT1 and breast cancer.